PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 21, 2025Frontiers in ImmunologyOpen Access

Salvianolic acid B: a promising cardioprotective agent

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Current research on salvianolic acid B in the context of cardiovascular diseases remains relatively fragmented.

Design

Review

Key result

Salvianolic acid B demonstrates comprehensive cardioprotective effects through antioxidant, anti-inflammatory, and anti-fibrotic mechanisms, highlighting its potential as a therapeutic agent for cardiovascular diseases.

Authors

YSYingchun ShaoLZLi ZhaiSJShan Jiang

Discussion

Loading...

Member takes

Overview

Salvianolic acid B may support cardioprotection but should not yet change practice; leaves open its role pending larger randomized trials.

Structured PICO

P
Population
Patients and preclinical models with cardiovascular diseases
I
Intervention
Salvianolic acid B (SalB)
O
Outcome
Cardioprotective effects and pharmacological mechanisms

Salvianolic acid B shows promise as a cardioprotective agent through multiple pharmacological mechanisms, warranting further research for clinical translation.

Limitations

  • Current research on SalB in the context of CVD remains relatively fragmented.
  • Absolute bioavailability is severely limited by intestinal instability, poor membrane permeability, and susceptibility to structural degradation.
  • Current research on SalB in the context of CVD remains relatively fragmented

Cite This Study

Shao et al. (2025) conducted a review in Cardiovascular diseases. Salvianolic acid B was evaluated. Salvianolic acid B demonstrates comprehensive cardioprotective effects through antioxidant, anti-inflammatory, and anti-fibrotic mechanisms, highlighting its potential as a therapeutic agent for cardiovascular diseases.

synapsesocial.com/papers/6a612e5798d8cb904426b7c2https://doi.org/10.3389/fimmu.2025.1681358
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Salvianolic acid B: a promising cardioprotective agent2025
  2. 2MYOCARDIUM PROTECTIVE FUNCTION OF SALVIANOLIC ACID B IN ISCHEMIA REPERFUSION RATS2016 · 35 citations
  3. 3Salvianolic Acid Exerts Cardioprotection through Promoting Angiogenesis in Animal Models of Acute Myocardial Infarction: Preclinical Evidence2017 · 53 citations
  4. 4Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling2010 · 70 citations
  5. 5Salvianolic Acid B-Alleviated Angiotensin II Induces Cardiac Fibrosis by Suppressing NF-κB Pathway In Vitro2018 · 36 citations